Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.
about
Biomarkers, diagnosis and management of sepsis-induced acute kidney injury: a narrative reviewCystatin C: a new renal marker and its potential use in small animal medicineA basic science view of acute kidney injury biomarkers.The impacts of thyroid function on the diagnostic accuracy of cystatin C to detect acute kidney injury in ICU patients: a prospective, observational study.Comparison of serum creatinine and serum cystatin C as biomarkers to detect sepsis-induced acute kidney injury and to predict mortality in CD-1 miceEvidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study.Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injuryDiagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injuryYear in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.Marking renal injury: can we move beyond serum creatinine?Role of biomarkers of nephrotoxic acute kidney injury in deliberate poisoning and envenomation in less developed countriesUrine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates.Serum cystatin is a useful marker for the diagnosis of acute kidney injury in critically ill children: prospective cohort studyCorrelations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndromeNephrotoxicity-induced proteinuria increases biomarker diagnostic thresholds in acute kidney injuryRole of new biomarkers: functional and structural damageClinical review: Biomarkers of acute kidney injury: where are we now?A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patients.Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill childrenDistinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function.Serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinineAre recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury?Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges.Novel biomarkers of acute kidney injury in the general adult ICU: a review.Biomarkers in the assessment of acute and chronic kidney diseases in the dog and cat.Predicting acute kidney injury: current status and future challenges.Serum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid.Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery.Comparison of different equations to assess glomerular filtration in critically ill patients.Systemic and urinary neutrophil gelatinase-associated lipocalins are poor predictors of acute kidney injury in unselected critically ill patients.Novel biomarkers for the prediction of acute kidney injury in patients undergoing liver transplantation.Cystatin C is not a reliable marker of residual glomerular filtration rate during continuous renal replacement therapy.Critical research on biomarkers: what's new?Effects of Oral Prednisone Administration on Serum Cystatin C in Dogs.Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients.Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine.Serum cystatin C and microalbuminuria in burn patients with acute kidney injury.Urinary cystatin C levels as a diagnostic and prognostic biomarker in patients with acute kidney injury.Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.Early biomarkers of renal injury and protective effect of erythropoietin on kidneys of asphyxiated newborn rats
P2860
Q26825317-94BBC1C2-9C11-4BB0-A611-142AFE30D822Q27010861-042107D2-C09C-4674-9D53-7E5EF9F6E8B3Q30384522-359C7F31-9E87-4C05-BF8C-983EB4BB3360Q33751865-16C26839-58DD-45F6-9593-87ABC6E85BF0Q34355926-5BDA85E4-DB15-4AD0-93F9-32CB01931006Q34489305-D761640D-621B-49A6-9AB7-14EDF8C32556Q35025281-87475242-684C-4620-BF62-92CABB77065BQ35666873-869771F6-E1B8-4039-9912-56A174CACC70Q35795306-E73A16BD-A37F-4824-AA0B-54C3AF456DF6Q35841388-68D242A0-D088-4205-B542-24B567DBFD60Q35846103-328EFAF2-F017-4DDF-8933-F26A5B0CF494Q35861370-B8CF70A4-E1F3-470C-90D1-A98219697742Q36131829-69CE92F5-375E-4752-8614-670A7E615904Q36265357-860B3ABF-45C7-4614-8115-E6A0BE1FA6DAQ36333111-7BF95E5D-FB7E-40CD-8819-220D54765B58Q36622423-732C5CAB-F0AD-48A0-AE2E-FD7DE96BE9FCQ36928048-BEAF282D-74CD-4BDC-8DC5-727647B6E581Q36928243-71D8946A-999A-4628-883B-FC6AAD425E0DQ37119704-DA3C467D-B3CF-4687-9A83-1860EF20E9E9Q37211307-0A789F26-DAA1-46AB-AA68-A0A30E2E1FC9Q37720428-9BF48246-4435-4059-BD84-860F82A65EAAQ38003686-96E1C8B6-DB06-4D5C-8013-62D4436EFF38Q38029606-D0B75332-583D-493D-B00C-F1E4B6204C42Q38087654-C0672767-D1FF-4E5D-A6B5-0FACA0D2A9DDQ38154953-6B94B2A0-7789-4CCE-A79A-553E51F7AD31Q38669818-31DBC83B-19C1-47F2-8BD6-99DC0BD99F1AQ38769018-3554F422-37F9-4DDC-8000-6094D1992646Q40282377-E167AA1F-060C-4FCA-9CA9-82D6B91C9B4AQ41529887-4EAB3657-CC42-4CCC-937D-FB567E09589AQ41643232-7DF48CF9-FA31-4DD2-AAE8-770C43FFDDE7Q42253777-D7B4D8FA-9804-4E5F-B1EC-1C504F1B3BF1Q42942433-7F8A64C3-F4C5-4E2F-B1A4-D5B6C824658DQ45055427-12C581AA-D50A-47B5-BF3C-87EE5F03DF8FQ47149470-AFE93477-6EDD-49C2-9C0A-36E9656B4393Q48247147-38A82CA8-E131-4CD8-B52E-BE2CD91107B7Q49073040-7FFFDAFB-D2DD-4966-902D-2931E258CA1BQ50928238-25004CA7-FA44-4F36-9858-EC4A92BB5DF4Q53340836-9FD28CE1-458D-475D-A92B-B69146CAA7D8Q55385257-DC66C08A-FB6E-4627-B090-C9B15346FCC9Q57938924-2C734D36-0AF5-4E71-A0E8-76D41AA0CBFD
P2860
Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Serum and urine cystatin C are ...... and renal replacement therapy.
@ast
Serum and urine cystatin C are ...... and renal replacement therapy.
@en
Serum and urine cystatin C are ...... and renal replacement therapy.
@nl
type
label
Serum and urine cystatin C are ...... and renal replacement therapy.
@ast
Serum and urine cystatin C are ...... and renal replacement therapy.
@en
Serum and urine cystatin C are ...... and renal replacement therapy.
@nl
prefLabel
Serum and urine cystatin C are ...... and renal replacement therapy.
@ast
Serum and urine cystatin C are ...... and renal replacement therapy.
@en
Serum and urine cystatin C are ...... and renal replacement therapy.
@nl
P2093
P2860
P1476
Serum and urine cystatin C are ...... and renal replacement therapy.
@en
P2093
Annick A N M Royakkers
Catherine S C Bouman
Jeroen D E van Suijlen
Johanna C Korevaar
Lieuwe S Hofstra
Peter E Spronk
P2860
P2888
P304
P356
10.1007/S00134-010-2087-Y
P577
2010-12-10T00:00:00Z